TOT BIOPHARM International Company Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 22.491 million compared to CNY 45.308 million a year ago. Operating loss was CNY 288.672 million compared to CNY 269.604 million a year ago. Net loss was CNY 288.498 million compared to CNY 299.300 million a year ago. Basic loss per share from continuing operations was CNY 0.51 compared to CNY 0.89 a year ago.